Quest Pharmatech Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the rating peer group for Quest Pharmatech Inc are shown below. Full Sustainability assessment of Quest Pharmatech Inc are accessed by logging in. If you work at Quest Pharmatech Inc and you would like to licence your ESG aseessment, please get in touch.
Quest Pharmatech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 0.0, social score of 0.0 and governance score of 8.0.
2.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1393 | Vaccinex Inc | 2.8 | Medium |
| 1393 | YSP Southeast Asia Holding Bhd | 2.8 | Medium |
| 1437 | Quest Pharmatech Inc | 2.7 | Medium |
| 1437 | CanadaBis Capital Inc | 2.7 | Medium |
| 1437 | Cannabics Pharmaceuticals Inc | 2.7 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Quest Pharmatech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Quest Pharmatech Inc report the average age of the workforce?
Sign up for free to unlockDoes Quest Pharmatech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Quest Pharmatech Inc offer flexible work?
Sign up for free to unlockDoes Quest Pharmatech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Quest Pharmatech Inc conduct supply chain audits?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Quest Pharmatech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose water use targets?
Sign up for free to unlockDoes Quest Pharmatech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Quest Pharmatech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Quest Pharmatech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Quest Pharmatech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Quest Pharmatech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Quest Pharmatech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Quest Pharmatech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose its waste policy?
Sign up for free to unlockDoes Quest Pharmatech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose energy use targets?
Sign up for free to unlockDoes Quest Pharmatech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Quest Pharmatech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Quest Pharmatech Inc
These potential risks are based on the size, segment and geographies of the company.
Quest PharmaTech Inc., a biopharmaceutical company, develops and commercializes antibody based immunotherapeutic products for cancer. Its lead product candidates are Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications; and Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. The company also develops combinatorial immunotherapeutic products for cancer by using monoclonal antibodies of the immunoglobulin G and E class in combination with chemotherapy/immune-adjuvant; and immunotherapy products for pancreatic cancer. In addition, it develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; and skin penetrating active molecules for cosmetic and pharmaceutical use. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.